Stock Market Tips

The Main & Aim markets of the London Stock Exchange are the world’s most successful Stock Markets.

The London Stock Exchange Main & AIM Markets are the world leading markets for the admission and trading of equity, debt and other securities. Located at the heart of the world’s pre-eminent financial centre makes them the ideal home to almost 2,000 companies from 100 countries, including many of the world’s largest, most successful and dynamic companies.

The Main & AIM Markets represents a badge of quality for every company admitted to and traded on them, and admission remains an aspiration for many companies worldwide.

The London Stock Exchange Main Market is home to almost 2,000 companies with a combined market cap of over £3 trillion. In the past five years alone, 555 companies have raised over £160bn on our Main Market segments and since 1995, over 3,865 companies have raised over £115bn on the AIM market alone, average amount of money raised during the past five years has been £21.4m.

There are four segments within the Main Market, each fulfilling different issuer requirements:

  • PREMIUM SEGMENT – The highest listing standards for the world’s leading companies
  • STANDARD SEGMENT – Core European listing standards for equity and GDR issuers
  • HIGH GROWTH SEGMENT – launch pad for growth businesses on their journey to the Premium Segment.
  • SPECIALIST FUND SEGMENT – Designed for investment funds that wish to target institutional investors or professionally advised investors only.

The variety of segments in the Main market, it can make it a good place for variable rate investments, Main Market Tips can prove to be lucrative with wise investments. Due to the fast moving nature and volatility of the AIM market, it can make it an exciting and more interesting place to invest. The following are a selection of the AIM and Main Stock Market Tips we are confident to provide to our members. For more AIM and Main Stock Market Tips, make sure you sign up to our monthly newsletter HERE.

Alliance Pharma – 36.1p

22 April 2024 - notice of results The AIM-listed pharmaceutical group has been forced to delay its annual results' announcement once again as the auditors, Deloitte LLP, have stated that...

Journeo – 257p

22 April 2024 - new contract The company has announced yet another new contract, this time in Sweden, for its transport information systems which will generate revenues of some £300,000...

Surgical Innovations – 0.5p

18 April 2024 - final results The AIM-listed technology group has announced its annual results for 2023 and these make for encouraging reading.  Revenues for the year rose 6% to...

Volex – 298p

18 April 2024 - trading update The power and data connection group has issued a trading update for the year to 31 March and this has confirmed that revenues for...